These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8728173)

  • 1. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.
    Mistry CD; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S104-8. PubMed ID: 8728173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview.
    Mistry CD; Gokal R
    Perit Dial Int; 1994; 14 Suppl 3():S158-61. PubMed ID: 7948266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal transport characteristics with glucose polymer based dialysate.
    Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?
    Rippe B; Zakaria el-R ; Carlsson O
    Perit Dial Int; 1996; 16 Suppl 1():S97-103. PubMed ID: 8728172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
    Mistry CD; Gokal R; Peers E
    Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
    Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
    Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icodextrin: overview of clinical experience.
    Peers E; Gokal R
    Perit Dial Int; 1997; 17(1):22-6. PubMed ID: 9068018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.
    Mistry CD; Mallick NP; Gokal R
    Lancet; 1987 Jul; 2(8552):178-82. PubMed ID: 2885639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucose polymer in the long dwell exchanges in peritoneal dialysis--advantages and limitations].
    Olszowska A
    Pol Merkur Lekarski; 2008 Apr; 24(142):355-8. PubMed ID: 18634373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucose polymer (icodextrin) as a component of fluid for peritoneal dialysis].
    Czyzewska K; Szary B; Grzegorzewska A
    Pol Arch Med Wewn; 1998 May; 99(5):417-22. PubMed ID: 9816893
    [No Abstract]   [Full Text] [Related]  

  • 13. The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis.
    Freida P; Wilkie M; Jenkins S; Dallas F; Issad B
    Kidney Int Suppl; 2008 Apr; (108):S102-11. PubMed ID: 18379532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid and solute transport in CAPD patients before and after permanent loss of ultrafiltration capacity.
    Waniewski J; Sobiecka D; Debowska M; Heimbürger O; Weryński A; Lindholm B
    Int J Artif Organs; 2005 Oct; 28(10):976-86. PubMed ID: 16288435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: The role for 'colloid' osmosis.
    Mistry CD; Gokal R
    Clin Sci (Lond); 1993 Oct; 85(4):495-500. PubMed ID: 8222517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threefold peritoneal test of osmotic conductance, ultrafiltration efficiency, and fluid absorption.
    Waniewski J; Paniagua R; Stachowska-Pietka J; Ventura MD; Ávila-Díaz M; Prado-Uribe C; Mora C; García-López E; Lindholm B
    Perit Dial Int; 2013; 33(4):419-25. PubMed ID: 23378471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.